Le Lézard
Classified in: Health
Subject: TDS

IFPBM invited to present at the International Symposium of Patient Blood Management in South Korea


BASEL, Switzerland, Nov. 30, 2017 /PRNewswire/ -- The International Symposium of Patient Blood Management 2017, hosted by the Korean Society for Patient Blood Management (KPBM), will be held in Seoul, South Korea 1-2 December 2017.

Dr. Young-Woo Kim, President of the KPBM and also an IFPBM Scientific Associate, states, "since the foundation of KBPM in 2014, we have brought people together to improve the quality, safety and efficiency of treatment with blood products in patient management." He added, "this symposium will provide great opportunities to share experiences and the latest academic information in the Patient Blood Management field."

Included among the international experts on Patient Blood Management who will give lectures at this symposium are Prof. Donat Spahn from the University Hospital Zurich, Switzerland, Prof. Aryeh Shander from the Englewood Hospital & Medical Center, USA and Prof. Toby Richards from the University College of London, UK.

IFPBM Director, A/Prof. Axel Hofmann, from the University Hospital Zurich, Switzerland, will deliver the opening address of the symposium entitled "Patient Blood Management: Has the paradigm shifted?"

The full program for the International Symposium of Patient Blood Management in South Korea may be viewed at www.isopbm.org.

About IFPBM

The International Foundation for Patient Blood Management (IFPBM) is a Swiss foundation headquartered in Basel, Switzerland.  IFPBM is a multi-disciplinary organization whose core purpose is to improve patient safety and outcomes in clinical practice through optimal Patient Blood Management.  IFPBM promotes evidence-based cost-effective practice through education and training, facilitating the highest standard of health care. 

To request a one-on-one meeting with representatives attending from IFPBM please email your request to [email protected].

SOURCE The International Foundation for Patient Blood Management (IFPBM)


These press releases may also interest you

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...

at 17:21
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...

at 17:15
Summary Product: Counterfeit Viagra, 100 mg sildenafil tabletsIssue: Health products - Product safety, Unauthorized productWhat to do: Immediately stop using and safely dispose of this product. Consult your health care provider if you have taken this...

at 17:00
GBLT Corp. ("GBLT" or the "Company") announces that minority shareholders have approved the voluntary delisting (the "Delisting") of the common shares of the Company from the TSX Venture Exchange ("TSXV").  Approval for the delisting was received at...



News published on and distributed by: